Cargando…
Building a Human Physiologically Based Pharmacokinetic Model for Aflatoxin B1 to Simulate Interactions with Drugs
Mycotoxins such as aflatoxin B1 (AFB1) are secondary fungal metabolites present in food commodities and part of one’s daily exposure, especially in certain regions, e.g., sub-Saharan Africa. AFB1 is mostly metabolised by cytochrome P450 (CYP) enzymes, namely, CYP1A2 and CYP3A4. As a consequence of c...
Autores principales: | Lootens, Orphélie, De Boevre, Marthe, Ning, Jia, Gasthuys, Elke, Van Bocxlaer, Jan, De Saeger, Sarah, Vermeulen, An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053806/ https://www.ncbi.nlm.nih.gov/pubmed/36986755 http://dx.doi.org/10.3390/pharmaceutics15030894 |
Ejemplares similares
-
Unravelling the pharmacokinetics of aflatoxin B1: In vitro determination of Michaelis–Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes
por: Lootens, Orphélie, et al.
Publicado: (2022) -
Possible Mechanisms of the Interplay between Drugs and Mycotoxins—Is There a Possible Impact?
por: Lootens, Orphélie, et al.
Publicado: (2022) -
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
por: De Sutter, Pieter-Jan, et al.
Publicado: (2023) -
Impact of Season, Region, and Traditional Agricultural Practices on Aflatoxins and Fumonisins Contamination in the Rice Chain in the Mekong Delta, Vietnam
por: Phan, Lien Thi Kim, et al.
Publicado: (2021) -
Calcination Enhances the Aflatoxin and Zearalenone Binding Efficiency of a Tunisian Clay
por: Rejeb, Roua, et al.
Publicado: (2019)